De Quervain’s tenosynovitis can make simple tasks: gripping, lifting, texting, opening jars, or caring for a child: painful. For your practice, it also presents a common clinical challenge: patients often need more than symptom management, but they may want to avoid corticosteroid injections or may not respond adequately to splinting alone.
JointWave™ high-intensity shockwave therapy offers a non-invasive adjunct to conservative care. Used with appropriate patient selection, thumb-spica splinting, activity modification, exercise, and chiropractic care, it can help reduce pain and improve upper-limb function.
This protocol provides a practical framework for chiropractors. It does not replace clinical judgment, medical referral, or formal JointWave™ device training.
Clear Diagnosis. Better Targeting. Safer Care.
De Quervain’s tenosynovitis affects the abductor pollicis longus (APL) and extensor pollicis brevis (EPB) tendons as they pass through the first dorsal compartment near the radial styloid.
Patients commonly report:
- Pain over the thumb-side wrist
- Tenderness at the radial styloid
- Pain with gripping, lifting, thumb abduction, or wrist deviation
- Swelling or thickening over the first dorsal compartment
- Reduced grip strength or difficulty using the thumb
Diagnosis remains primarily clinical. A positive Finkelstein or Eichhoff maneuver supports the diagnosis, but interpret provocative testing alongside the patient’s history and palpation findings. Avoid repeatedly provoking a highly irritable tendon sheath.
Ultrasound can help when the presentation is atypical, when you need to evaluate the tendon sheath, or when you suspect a septum separating the APL and EPB compartments.
Rule Out Look-Alikes. Protect the Patient. Protect the Outcome.
Radial wrist pain does not always equal De Quervain’s. Consider referral or additional evaluation when findings suggest:
- Thumb carpometacarpal osteoarthritis: pain at the thumb base, crepitus, or a positive grind test
- Intersection syndrome: pain and swelling more proximal on the dorsal radial forearm
- Scaphoid or radial styloid fracture: trauma, focal bony tenderness, or concerning radiographs
- Wartenberg syndrome: burning, tingling, or sensory changes over the radial hand
- Flexor carpi radialis tendinopathy: volar-radial wrist tenderness
- Trigger thumb: catching or locking at the volar thumb near the A1 pulley
Use radiographs when fracture or osteoarthritis is a concern. Consider diagnostic ultrasound when anatomy, tendon involvement, or a failed prior intervention creates uncertainty.
Evidence-Based. Non-Invasive. Patient-Centered.
Conservative management remains the foundation of care. A forearm-based thumb-spica orthosis, activity modification, and graded rehabilitation should form the baseline plan.
The evidence for ESWT in De Quervain’s remains promising but limited. A randomized clinical trial of 26 patients used three weekly sessions of ESWT alongside a thumb-spica splint and conservative medication. The ESWT group achieved significantly better VAS pain and DASH function scores than the sham group.
A 2024 network meta-analysis of 14 randomized controlled trials found that ESWT produced statistically significant short-term pain improvement versus placebo and ranked highly for medium-term VAS outcomes. However, the same review concluded that corticosteroid injection combined with short-term immobilization remains a primary evidence-supported treatment.
That distinction matters. JointWave™ should complement: not automatically replace: first-line conservative care. It becomes especially relevant for patients who:
- Prefer to avoid corticosteroid injections
- Have contraindications to injection
- Experienced unsatisfactory results from injection
- Continue to experience pain after a reasonable trial of splinting and activity modification
- Need a non-invasive option within a broader rehabilitation plan
Controlled Energy. Precise Contact. Progressive Loading.
Shockwave therapy delivers mechanical acoustic energy to the target tissue. The proposed effects include mechanotransduction, modulation of pain signaling, local vascular response, and support of tissue remodeling. The exact mechanism in De Quervain’s remains incompletely understood, so describe the treatment accurately: a non-invasive modality that may reduce pain and improve function as part of multimodal care.
Because the first dorsal compartment lies close to the skin and superficial radial nerve, more energy and greater depth do not automatically produce better results. Treat the target: not the maximum setting.
A Conservative JointWave™ Treatment Framework
Always follow current JointWave™ training, device labeling, and applicable local regulations. Settings vary by device, applicator, energy terminology, and clinical presentation.
Before Session 1
- Record pain using a 0–10 VAS or NRS.
- Document QuickDASH or DASH function when appropriate.
- Measure grip strength if available and clinically useful.
- Palpate the radial styloid and map the most symptomatic portion of the first dorsal compartment.
- Record aggravating activities and establish a functional goal, such as lifting a child or gripping without pain.
- Screen for red flags, neurological symptoms, infection, anticoagulation or bleeding risk, fracture, and other device-specific contraindications.
Session 1: Confirm Tolerance.
Apply coupling gel and position the patient comfortably with the wrist supported. Use a small, controlled treatment area over the symptomatic first dorsal compartment and begin at the lower end of the trained JointWave™ energy range. Keep the applicator moving as appropriate for the device and patient response. Avoid aggressive pressure directly over the radial styloid or superficial radial nerve.
A published De Quervain’s ESWT trial used 1,000 impulses at 2 bar and 15 Hz. Consider that a literature reference: not a universal JointWave™ prescription. Do not transfer settings between devices without formal training.
Session 2: Repeat with Clinical Control.
Typically schedule treatment approximately one week later. Recheck pain, tenderness, thumb motion, and post-session response. Maintain or modestly progress the dose only when the patient tolerated Session 1 without an excessive flare. A mild, temporary increase in local sensitivity can occur; significant or prolonged aggravation warrants reassessment.
Session 3: Reassess Function.
Repeat the same outcome measures. The published randomized trial used three weekly sessions and reported pain and DASH improvements after treatment and at follow-ups. If pain and function improve, transition the patient toward progressive loading rather than automatically adding more sessions.
Session 4 or Later: Use Criteria, Not Habit.
Consider an additional session only when the diagnosis remains appropriate, the patient demonstrates partial improvement, and the expected benefit justifies continued care. Reconsider the diagnosis or refer when symptoms remain unchanged, neurological signs develop, trauma emerges, or the patient cannot tolerate treatment.
Splinting. Exercise. Adjustments.
JointWave™ works best inside a complete plan.
Orthosis and Activity Modification
Use a comfortable thumb-spica orthosis that limits painful wrist and thumb motion while allowing interphalangeal joint movement. Wear time should match your clinical assessment and the patient’s irritability. Educate patients to reduce repetitive thumb abduction, forceful gripping, lifting with the wrist deviated, and prolonged phone or gaming positions.
Exercise and Rehabilitation
During the irritable phase, emphasize gentle, pain-limited active range of motion. Do not forcefully stretch into a painful Finkelstein position.
As symptoms settle, progress to:
- Pain-free thumb abduction and extension
- Gentle isometric thumb and wrist work
- Controlled grip retraining
- Progressive resisted APL and EPB loading
- Ergonomic retraining for work, childcare, sport, and device use
Use symptoms and next-day response to guide progression. A patient who reports less pain but continues to overload the tendon may relapse.
Chiropractic Integration
Chiropractic adjustment can support the broader care plan when examination identifies relevant joint or regional dysfunction. Address the cervical spine, shoulder girdle, elbow, forearm, and wrist mechanics as clinically indicated.
A practical sequence may include:
- Assess regional mechanics and neurologic status.
- Perform appropriate adjustment or mobilization away from the acutely irritable tendon sheath.
- Apply JointWave™ to the confirmed first dorsal compartment target.
- Finish with education, orthosis guidance, and the next rehabilitation step.
Avoid aggressive local manipulation over an acutely painful tendon sheath. Integration should improve movement options: not add mechanical irritation.
Measurable Progress. Realistic Expectations. Better Decisions.
Patients may notice short-term pain modulation, but tissue adaptation and functional improvement often develop over several weeks. Set expectations around trends rather than guarantees:
- Pain may improve across the first few sessions
- Grip and daily function may improve as irritability decreases
- Benefits may continue after the treatment series ends
- Follow-up at three to six weeks helps assess durability
- Persistent symptoms require diagnostic reconsideration, not endless treatment
The available trials reported statistically significant improvements in VAS pain and upper-limb function, but they used small samples and varied protocols. Long-term comparative evidence remains less developed than the evidence for corticosteroid injection with immobilization.
Durable Heads. Better ROI. Complete Support.
Your technology investment must support both patient care and clinic operations. JointWave™ treatment heads are technologically superior and engineered for high-volume clinical use, with durability designed to outlast major competitors. JointWave materials describe treatment heads rated for 400,000+ clicks, helping reduce replacement frequency and support a lower cost per treatment.
JointWave also supports implementation beyond the equipment:
- ✅ White-glove installation
- ✅ Staff training for confident workflow integration
- ✅ Marketing materials for patient education
- ✅ Guidance for identifying appropriate cases
- ✅ A cash-based service that complements existing chiropractic care
Your practice can try JointWave™ risk-free for 30 days in-office with no obligation. Treat appropriate patients, track outcomes, evaluate workflow, and determine whether the system fits your clinical and business goals.
Start Your Risk-Free Trial.
If your patients with De Quervain’s want a non-invasive option beyond splinting: or if injections are contraindicated, undesired, or unsatisfactory: build a measured, conservative JointWave™ protocol into your care model.
Visit jointwavetrial.com and start your risk-free 30-day in-office trial today.
Clinical disclaimer: This article is for educational purposes only. It does not replace individualized clinical judgment, diagnosis, referral, medical evaluation, informed consent, or formal JointWave™ device training. Follow the current device instructions for use, applicable regulations, and your professional scope of practice. Clinical outcomes vary.
Clinical References
- Chong J, Pradhan S, Dhingra R, et al. Advancements in de Quervain Tenosynovitis Management: A Comprehensive Network Meta-Analysis. PubMed.
- Haghighat S, Vahdatpour B, Ataei E. “The Effect of Extracorporeal Shockwave Therapy on de Quervain Tenosynovitis; a Clinical Trial.” Shiraz E-Medical Journal. 2021;22(8):e106559. Full text.
- “Efficacy of Extracorporeal Shockwave Therapy and High-Intensity Laser Therapy in De Quervain Tenosynovitis.” Turkish Journal of Physical Medicine and Rehabilitation. 2025. PubMed.
- Huisstede BM, Gladdines S, Randsdorp MS, Koes BW. “Effectiveness of Conservative, Surgical, and Postsurgical Interventions for Trigger Finger, Dupuytren Disease, and De Quervain Disease.” Archives of Physical Medicine and Rehabilitation. 2018;99:1635–1649. PubMed.
- Goel R, Abzug JM. “De Quervain’s Tenosynovitis: A Review of the Rehabilitative Options.” HAND. 2015;10(1):1–5. DOI.